Stock Rise Follows I-Flow Device Approval

I-Flow Corp.’s stock rose $1.66 a share, or 41%, to $5.69 a share after the Lake Forest maker of infusion systems said the U.S. Food and Drug Administration will allow the company to market its new catheter for pain management of large surgical incisions.